EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dual regulation of CXCR6 + CD8 + T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression

Zhang Xingming, Jianhua Wang, Mierxiati Abudurexiti, Leilei Du, Wei Zhang, Xudong Ni, Midie Xu, Xiaoyan Zhang, Min Zhang, Zhu Yao, Xiaojie Bian, Shengming Jin und 1 weitere

Journal for ImmunoTherapy of Cancer · 2026-03 · 14 (3) · e014276

DOI: 10.1136/jitc-2025-014276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 11.03.2026. Verfasst von Zhang Xingming und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Receptors, CXCR6, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shanghai Anticancer Association EYAS PROJECT, The Healthcare Talents Youth Program of Shanghai Pudong New Area, Key Discipline Development Initiative of the Shanghai Health System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer (PCa) is widely recognized as an immunologically “cold” tumor, characterized by a paucity of effector T cells and a limited response to immune checkpoint blockade therapy. Although the chemokine receptor CXCR6 has been identified as a marker of highly cytotoxic CD8 + T cells in other malignancies, its identity, regulatory mechanisms, and clinical significance in PCa remain poorly understood.

Methods

We integrated newly generated and publicly available single-cell RNA sequencing data encompassing 90 651 cells from nine patients. Multicolor immunofluorescence and flow cytometry were performed on human PCa tissue specimens stratified by Gleason Score (GS). In parallel, syngeneic mouse models, bone marrow chimeras, and in vitro T-cell functional assays were employed to investigate the role, recruitment, and transcriptional regulation of CXCR6 + CD8 + T cells. Mechanistic investigations included bulk RNA-seq, chromatin immunoprecipitation-quantitative real-time PCR, pharmacologic modulation of FOXO1, and detailed analysis of the IL-10–STAT3 signaling pathway.

Results

The CXCR6 + CD8 + T cells represent a transcriptionally distinct subset with high expression of cytotoxic markers ( GZMA , GZMB , and PRF1 ), and their frequency declines significantly with increasing GS. Intratumoral maintenance of these cells is sustained by CXCL16 secreted by IL1B + M1-like macrophages; the loss of this macrophage population in advanced tumors leads to depletion of CXCR6 + CD8 + T cells. Genetic ablation of CXCR6 or depletion of CD8 + T cells accelerates tumor growth, demonstrating the essential role of CXCR6 + CD8 + T cells in antitumor immunity. At the molecular level, the FOXO1–KLF2 axis transcriptionally represses CXCR6 expression, and IL-10-mediated activation of STAT3 upregulates FOXO1 and KLF2, thereby suppressing CXCR6 expression and impairing cytotoxic function. Pharmacologic inhibition of FOXO1 enhances the expansion of CXCR6 + CD8 + T cells and acts synergistically with anti-PD-1 therapy to inhibit tumor progression.

Conclusions

The CXCR6 + CD8 + T cells are critical yet progressively diminished effectors in PCa. Their persistence within the tumor microenvironment depends on CXCL16 derived from M1-like macrophages and is counteracted by IL-10-driven FOXO1–KLF2 signaling. Targeting this regulatory axis—through inhibition of FOXO1 or IL-10, for example—represents a rational therapeutic strategy to restore CXCR6 + CD8 + T-cell-mediated immunity and enhance the efficacy of immunotherapy in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsReceptors, CXCR6CD8-Positive T-LymphocytesMaleHumansAnimalsMiceDisease ProgressionT-Cell ExhaustionTumor Microenvironment

Stichwörter der Autor:innen

ImmunotherapyProstate CancerT cellTumor microenvironment - TME

Substanzen

Receptors, CXCR6CXCR6 protein, human

Autor:innen und Institutionen

  • Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China jianhuaw2007@qq.com wangwenfeng1011@163.com jsmfdu@163.com xbian10@fudan.edu.cn.
  • Department of Urology, Pudong Gongli Hospital, Shanghai University of Medicine & Health Sciences, Shanghai, China.
  • Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.

Förderung

  • Shanghai Anticancer Association EYAS PROJECT
  • The Healthcare Talents Youth Program of Shanghai Pudong New Area
  • Key Discipline Development Initiative of the Shanghai Health System
  • National Key Clinical Specialty Construction Project
  • National Natural Science Foundation of China
  • Shanghai Anticancer Association-Fudan University Shanghai Cancer Center Joint Funding
  • New Quality Clinical Specialty Program of High-end Medical Disciplinary Construction in Shanghai Pudong New Area

Zitieren

APA

Xingming, Z., Wang, J., Abudurexiti, M., Du, L., Zhang, W., Ni, X., Xu, M., Zhang, X., Zhang, M., Yao, Z., Bian, X., Jin, S., & Wang, W. (2026). Dual regulation of CXCR6 + CD8 + T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression. Journal for ImmunoTherapy of Cancer, 14(3), e014276. https://doi.org/10.1136/jitc-2025-014276

Vancouver

Xingming Z, Wang J, Abudurexiti M, Du L, Zhang W, Ni X, et al. Dual regulation of CXCR6 + CD8 + T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression. Journal for ImmunoTherapy of Cancer. 2026;14(3):e014276. doi:10.1136/jitc-2025-014276

BibTeX
@article{Xingming2026,
  author = {Xingming, Zhang and Wang, Jianhua and Abudurexiti, Mierxiati and Du, Leilei and Zhang, Wei and Ni, Xudong and Xu, Midie and Zhang, Xiaoyan and Zhang, Min and Yao, Zhu and Bian, Xiaojie and Jin, Shengming and Wang, Wenfeng},
  title = {Dual regulation of CXCR6 + CD8 + T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {e014276},
  doi = {10.1136/jitc-2025-014276}
}
Kostenlos starten →